Bottom line
What does LHCFX hold?
LHCFX held 61 positions as of Jul 31, 2026. Its largest holding is Eli Lilly & Co at 10.40% of the fund, and the top 10 positions add up to 42.9%. By asset type it is 98% stocks, 1% repurchase agreements, 1% cash & short-term funds.
Updated Sep 25, 2026
LHCFX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | Stocks | 10.40% | $890.4K |
| 2 | UnitedHealth Group Inc | Stocks | 5.39% | $462.1K |
| 3 | Johnson & Johnson | Stocks | 4.96% | $424.5K |
| 4 | Novartis AG | Stocks | 4.19% | $358.4K |
| 5 | Natera Inc | Stocks | 3.60% | $308.2K |
| 6 | Gilead Sciences Inc | Stocks | 3.53% | $302.5K |
| 7 | CVS Health Corp | Stocks | 3.33% | $285.5K |
| 8 | Guardant Health Inc | Stocks | 2.61% | $223.7K |
| 9 | Galderma Group AG | Stocks | 2.60% | $222.6K |
| 10 | Thermo Fisher Scientific Inc | Stocks | 2.31% | $198.1K |
| 11 | Cogent Biosciences Inc | Stocks | 2.27% | $194.0K |
| 12 | Vertex Pharmaceuticals Inc | Stocks | 2.24% | $191.8K |
| 13 | 10X Genomics Inc | Stocks | 2.16% | $184.8K |
| 14 | BeOne Medicines Ltd | Stocks | 2.06% | $176.3K |
| 15 | Ascendis Pharma A/S | Stocks | 1.99% | $170.2K |
| 16 | AstraZeneca PLC | Stocks | 1.97% | $168.7K |
| 17 | Madrigal Pharmaceuticals Inc | Stocks | 1.91% | $163.6K |
| 18 | Bridgebio Pharma Inc | Stocks | 1.84% | $157.7K |
| 19 | Edwards Lifesciences Corp | Stocks | 1.78% | $152.8K |
| 20 | Revolution Medicines Inc | Stocks | 1.67% | $143.3K |
| 21 | Arrowhead Pharmaceuticals Inc | Stocks | 1.52% | $130.2K |
| 22 | Protagonist Therapeutics Inc | Stocks | 1.44% | $123.7K |
| 23 | Dianthus Therapeutics Inc | Stocks | 1.44% | $123.2K |
| 24 | Adaptive Biotechnologies Corp | Stocks | 1.42% | $122.0K |
| 25 | Illumina Inc | Stocks | 1.42% | $121.8K |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 25, 2026